MDL-100,453 je antagonist NMDA receptora.[3]

MDL-100,453
(2R)-2-amino-4-oxo-5-phosphonopentanoic acid
Nazivi
IUPAC naziv
(2R)-2-amino-4-okso-5-fosfonopentanoinska kiselina
Drugi nazivi
  • 4-Okso-5-fosfononorvalin
  • 129938-34-7
  • CHEMBL431029
  • MDL100483
  • MDL 100,453
Identifikacija
3D model (Jmol)
  • C(C(C(=O)O)N)C(=O)CP(=O)(O)O
Svojstva
C5H10NO6P
Molarna masa 211,11 g·mol−1
Ukoliko nije drugačije napomenuto, podaci se odnose na standardno stanje materijala (na 25 °C [77 °F], 100 kPa).
Reference infokutije

Reference

uredi
  1. ^ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003.  uredi
  2. ^ Evan E. Bolton; Yanli Wang; Paul A. Thiessen; Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry. 4: 217—241. doi:10.1016/S1574-1400(08)00012-1. 
  3. ^ D. E. Jane; H. W. Tse; D. A. Skifter; J. M. Christie; D. T. Monaghan. Pharmacology of Ionic Channel Function: Activators and Inhibitors. Glutamate Receptor Ion Channels: Activators and Inhibitors. Pharmacology of Ionic Channel Function: Activators and Inhibitors. Springer. str. 415—478.